Atlas Trials

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Clinical trial NCT02867592 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02867592
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System NeoplasmChildhood Clear Cell Sarcoma of Soft TissueClear Cell Sarcoma of Soft TissueEwing SarcomaHepatoblastomaHepatocellular CarcinomaOsteosarcomaRecurrent Adrenal Cortical CarcinomaRecurrent Alveolar Soft Part SarcomaRecurrent Clear Cell Sarcoma of Soft Tissue
Start date
2017-05-18
Primary completion
2021-06-30
Enrollment
109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.